These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21678921)

  • 41. Product specificity and mechanism of protein lysine methyltransferases: insights from the histone lysine methyltransferase SET8.
    Zhang X; Bruice TC
    Biochemistry; 2008 Jun; 47(25):6671-7. PubMed ID: 18512960
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Catalytic mechanism and product specificity of rubisco large subunit methyltransferase: QM/MM and MD investigations.
    Zhang X; Bruice TC
    Biochemistry; 2007 May; 46(18):5505-14. PubMed ID: 17429949
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Histone lysine methyltransferase SET7/9: formation of a water channel precedes each methyl transfer.
    Zhang X; Bruice TC
    Biochemistry; 2007 Dec; 46(51):14838-44. PubMed ID: 18044969
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mechanism of multiple lysine methylation by the SET domain enzyme Rubisco LSMT.
    Trievel RC; Flynn EM; Houtz RL; Hurley JH
    Nat Struct Biol; 2003 Jul; 10(7):545-52. PubMed ID: 12819771
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mutational analysis of the catalytic domain of the murine Dnmt3a DNA-(cytosine C5)-methyltransferase.
    Gowher H; Loutchanwoot P; Vorobjeva O; Handa V; Jurkowska RZ; Jurkowski TP; Jeltsch A
    J Mol Biol; 2006 Mar; 357(3):928-41. PubMed ID: 16472822
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structure analysis of the conserved methyltransferase domain of human trimethylguanosine synthase TGS1.
    Monecke T; Dickmanns A; Strasser A; Ficner R
    Acta Crystallogr D Biol Crystallogr; 2009 Apr; 65(Pt 4):332-8. PubMed ID: 19307714
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The lysine methyltransferases SET and MYND domain containing 2 (Smyd2) and Enhancer of Zeste 2 (Ezh2) co-regulate osteoblast proliferation and mineralization.
    Dashti P; van de Peppel J; Thaler R; Paradise CR; Stein GS; Montecino MA; van Leeuwen JPTM; van der Eerden BJ; Dudakovic A; van Wijnen AJ
    Gene; 2023 Jan; 851():146928. PubMed ID: 36191822
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Discovery and Characterization of a Highly Potent and Selective Aminopyrazoline-Based in Vivo Probe (BAY-598) for the Protein Lysine Methyltransferase SMYD2.
    Eggert E; Hillig RC; Koehr S; Stöckigt D; Weiske J; Barak N; Mowat J; Brumby T; Christ CD; Ter Laak A; Lang T; Fernandez-Montalvan AE; Badock V; Weinmann H; Hartung IV; Barsyte-Lovejoy D; Szewczyk M; Kennedy S; Li F; Vedadi M; Brown PJ; Santhakumar V; Arrowsmith CH; Stellfeld T; Stresemann C
    J Med Chem; 2016 May; 59(10):4578-600. PubMed ID: 27075367
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of the Substrate Specificity of the SMYD2 Protein Lysine Methyltransferase and Discovery of Novel Non-Histone Substrates.
    Weirich S; Schuhmacher MK; Kudithipudi S; Lungu C; Ferguson AD; Jeltsch A
    Chembiochem; 2020 Jan; 21(1-2):256-264. PubMed ID: 31612581
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mechanism of histone methylation catalyzed by protein lysine methyltransferase SET7/9 and origin of product specificity.
    Guo HB; Guo H
    Proc Natl Acad Sci U S A; 2007 May; 104(21):8797-802. PubMed ID: 17517655
    [TBL] [Abstract][Full Text] [Related]  

  • 51. LLY-507, a Cell-active, Potent, and Selective Inhibitor of Protein-lysine Methyltransferase SMYD2.
    Nguyen H; Allali-Hassani A; Antonysamy S; Chang S; Chen LH; Curtis C; Emtage S; Fan L; Gheyi T; Li F; Liu S; Martin JR; Mendel D; Olsen JB; Pelletier L; Shatseva T; Wu S; Zhang FF; Arrowsmith CH; Brown PJ; Campbell RM; Garcia BA; Barsyte-Lovejoy D; Mader M; Vedadi M
    J Biol Chem; 2015 May; 290(22):13641-53. PubMed ID: 25825497
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of a novel histone H3K36 methyltransferase setd3 in zebrafish.
    Kim DW; Kim KB; Kim JY; Seo SB
    Biosci Biotechnol Biochem; 2011; 75(2):289-94. PubMed ID: 21307598
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Targeting Epigenetic Changes Mediated by Members of the SMYD Family of Lysine Methyltransferases.
    Padilla A; Manganaro JF; Huesgen L; Roess DA; Brown MA; Crans DC
    Molecules; 2023 Feb; 28(4):. PubMed ID: 36838987
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quantitative Profiling of the Activity of Protein Lysine Methyltransferase SMYD2 Using SILAC-Based Proteomics.
    Olsen JB; Cao XJ; Han B; Chen LH; Horvath A; Richardson TI; Campbell RM; Garcia BA; Nguyen H
    Mol Cell Proteomics; 2016 Mar; 15(3):892-905. PubMed ID: 26750096
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The ribosomal protein eL21 interacts with the protein lysine methyltransferase SMYD2 and regulates its steady state levels.
    Khan MIK; Charles RCM; Ramachandran R; Gupta S; Govindaraju G; Mishra R; Rajavelu A; Coumar MS; Chavali S; Dhayalan A
    Biochim Biophys Acta Mol Cell Res; 2021 Aug; 1868(9):119079. PubMed ID: 34147559
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mechanistic and functional extrapolation of SET and MYND domain-containing protein 2 to pancreatic cancer.
    Alshammari E; Zhang YX; Yang Z
    World J Gastroenterol; 2022 Aug; 28(29):3753-3766. PubMed ID: 36157542
    [TBL] [Abstract][Full Text] [Related]  

  • 57. SMYD2 Drives Mesendodermal Differentiation of Human Embryonic Stem Cells Through Mediating the Transcriptional Activation of Key Mesendodermal Genes.
    Bai HJ; Zhang P; Ma L; Liang H; Wei G; Yang HT
    Stem Cells; 2019 Nov; 37(11):1401-1415. PubMed ID: 31348575
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A fluorescence-based supramolecular tandem assay for monitoring lysine methyltransferase activity in homogeneous solution.
    Florea M; Kudithipudi S; Rei A; González-Álvarez MJ; Jeltsch A; Nau WM
    Chemistry; 2012 Mar; 18(12):3521-8. PubMed ID: 22367964
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An Integrative Proteomic Approach Identifies Novel Cellular SMYD2 Substrates.
    Ahmed H; Duan S; Arrowsmith CH; Barsyte-Lovejoy D; Schapira M
    J Proteome Res; 2016 Jun; 15(6):2052-9. PubMed ID: 27163177
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Coordination of stress signals by the lysine methyltransferase SMYD2 promotes pancreatic cancer.
    Reynoird N; Mazur PK; Stellfeld T; Flores NM; Lofgren SM; Carlson SM; Brambilla E; Hainaut P; Kaznowska EB; Arrowsmith CH; Khatri P; Stresemann C; Gozani O; Sage J
    Genes Dev; 2016 Apr; 30(7):772-85. PubMed ID: 26988419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.